Status:
COMPLETED
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase
Lead Sponsor:
The George Institute for Global Health, China
Collaborating Sponsors:
University of Edinburgh
Huashan Hospital
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
ASPIRING is an investigator-led, multicentre, prospective, randomised, open-label, blind outcome (PROBE), parallel group, clinical trial. The pilot phase will explore the feasibility of conducting a t...
Detailed Description
The participant eligibility criteria specifically identify adults with history of symptomatic spontaneous ICH. Randomisation occurs if a participant and their doctor are uncertain about whether to sta...
Eligibility Criteria
Inclusion
- Patient age ≥18 years.
- Symptomatic stroke due to spontaneous (non-traumatic) ICH.
- Patient is at least 24 hours after ICH symptom onset.
- Patient and their doctor are both uncertain about whether to start or avoid antiplatelet monotherapy.
- Consent to randomisation from the patient (or personal / legal / professional representative if the patient does not have mental capacity).
Exclusion
- ICH due to head injury, in the opinion of the investigator.
- ICH due to haemorrhagic transformation of an ischaemic stroke, in the opinion of the investigator.
- Patient is already taking antiplatelet therapy, or full dose anticoagulant therapy, after ICH.
- Patient is pregnant, breastfeeding, or of childbearing age and not taking contraception.
- Patient and carer unable to understand spoken or written local language.
Key Trial Info
Start Date :
September 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04522102
Start Date
September 3 2021
End Date
October 13 2023
Last Update
March 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The George Institute for Global Health
Beijing, Beijing Municipality, China, 100088
2
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200000